GT Biopharma, Inc.·4

Feb 1, 6:01 AM ET

Wendel Bruce 4

4 · GT Biopharma, Inc. · Filed Feb 1, 2023

Insider Transaction Report

Form 4
Period: 2023-01-27
Wendel Bruce
Director
Transactions
  • Award

    Option to purchase Common Stock

    2023-01-27+500,000500,000 total
    Exercise: $0.84Exp: 2033-01-26Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct.

Documents

1 file
  • 4
    ownership.xmlPrimary